Sanofi SA
NASDAQ:SNY

Watchlist Manager
Sanofi SA Logo
Sanofi SA
NASDAQ:SNY
Watchlist
Price: 46.74 USD 0.52% Market Closed
Market Cap: $116.8B

Operating Margin

23.6%
Current
Improving
by 1.2%
vs 3-y average of 22.4%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
23.6%
=
Operating Income
€15.8B
/
Revenue
€66.9B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
23.6%
=
Operating Income
$15.8B
/
Revenue
€66.9B

Peer Comparison

Country Company Market Cap Operating
Margin
FR
Sanofi SA
PAR:SAN
96.5B EUR
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.7B USD
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
US
Merck & Co Inc
NYSE:MRK
267.9B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
169B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.6B USD
Loading...
DE
Bayer AG
XETRA:BAYN
43.8B EUR
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
F:1PK
5.1B EUR
Loading...
CH
Roche Holding AG
SIX:ROG
275.3B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...

Market Distribution

Higher than 90% of companies in France
Percentile
90th
Based on 2 333 companies
90th percentile
23.6%
Low
-17 526.7% — 1.3%
Typical Range
1.3% — 11.5%
High
11.5% — 89 700%
Distribution Statistics
France
Min -17 526.7%
30th Percentile 1.3%
Median 6.1%
70th Percentile 11.5%
Max 89 700%

Sanofi SA
Glance View

Sanofi SA, a titan in the global healthcare sector, operates at the intricate crossroads of pharmaceutical innovation and patient care, driven by an unyielding commitment to improving human health. Emerging from its French roots, Sanofi has strategically positioned itself as a global leader in pharmaceuticals, vaccines, and consumer healthcare. The company’s success is essentially anchored in its capacity to consistently develop and commercialize life-saving drugs that address a myriad of health concerns, ranging from diabetes and cardiovascular diseases to rare disorders and oncology. Underlining its robust revenue engine is Sanofi's extensive R&D infrastructure that fuels its pipeline with groundbreaking therapies, reflecting a dynamic blend of scientific acumen and market-focused agility. By leveraging a hybrid model that integrates cutting-edge research with strategic alliances and acquisitions, Sanofi ensures a sustained presence in the highly competitive biopharmaceutical landscape. Enabling this network of innovation and impact is Sanofi's diverse portfolio, a balanced mix of specialty and established prescription drugs, over-the-counter products, and the critical arm of vaccines led by its Sanofi Pasteur division. This diversification offers both growth opportunities and stability, cushioning against the volatile tides of patent expirations and regulatory changes. Its vaccines segment, in particular, is a cornerstone in Sanofi's business, capturing substantial market share with products critical to global immunization efforts, further amplified by its role in responding to health emergencies like the COVID-19 pandemic. With a geographically expansive sales footprint and strategic marketing strategies, Sanofi capitalizes on emerging market opportunities while maintaining a strong presence in established regions, effectively making its bottom line a testimony to its operational excellence and strategic foresight in harmonizing science with humanity.

SNY Intrinsic Value
92.94 USD
Undervaluation 50%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
23.6%
=
Operating Income
€15.8B
/
Revenue
€66.9B
What is Sanofi SA's current Operating Margin?

The current Operating Margin for Sanofi SA is 23.6%, which is above its 3-year median of 22.4%.

How has Operating Margin changed over time?

Over the last 3 years, Sanofi SA’s Operating Margin has increased from 22.1% to 23.6%. During this period, it reached a low of 19.7% on Dec 31, 2024 and a high of 26% on Jun 30, 2023.

Back to Top